6 TECH OUTLOOKMarch - 2020EditorialStacey Smith Editor-in-Chiefeditor@pharmatechoutlook.comThe pharma industry has already been a witness to remarkable advancements in terms of technology. However, academia and pharma professionals are still scratching the surface when it comes to the discovery of improved drugs and better diagnoses. Vendors are still attempting to achieve the two-fold objective of introducing new products to the market and improving the lives of patients in a continually evolving global front. Most companies are still in the mapping phase in order to adopt a future-ready approach for better patient outcomes. On the positive side, the obstacles in achieving the target along with the potential shortcuts that can help professionals reach their goals became more defined in 2019. With data-driven insights at play, it has now become easier to understand the needs of care receivers.Big data and data analytics form the fulcrum of the patient-centric model in the pharma industry. The study of medical histories and genetics has made it possible for pharma professionals to detect early signs of any health deterioration and address them promptly. More so, patients are also able to take control of their own health with the aid of personalized drugs that are developed considering the medical conditions of patients.In this edition, we have put together stories that talk about the exemplary transformation of the pharma landscape as it walks the journey of evolving into a futuristic realm. With incisive perceptions from seasoned entrepreneurs, we hope to present to you descriptive pieces about big data analytics and its relevance in the pharmaceutical space. We have zeroed in on the providers that understand your business needs and can connect you to the right solutions. A panoramic view of their solutions and services will be a first step toward building a secure future for your enterprise.Let us know your thoughts.Smart Analytics for Better Patient OutcomesCopyright © 2020 ValleyMedia Inc. All rights reserved. Reproduction in whole or part of any text, photography or illustrations without written permission from the publisher is prohibited. The publisher assumes no responsibility for unsolicited manuscripts, photographs or illustrations. Views and opinions expressed in this publication are not necessarily those of the magazine and accordingly, no liability is assumed by the publisher thereof.MARCH - 02 - 2020, Vol 06 - Issue 03 (ISSN 2644-2787) Published by ValleyMedia Inc. To subscribe to Pharma Tech OutlookVisit www.pharmatechoutlook.com *Some of the Insights are based on the interviews with respective CIOs and CXOs to our editorial staffEditor-in-ChiefStacey SmithVisualizerAsher BlakeEditorial StaffAaron Pierce Ava GarciaJenna VegasCarolynn Walters Justin SmithPaul BarberSalesBrian Thomasbrian@pharmatechoutlook.comPhone: 510.556.2402sales@pharmatechoutlook.comeditor@pharmatechoutlook.commarketing@pharmatechoutlook.comEmail:Contact Us:Phone:510.556.2402, Fax:510-894-8405David ParkerTECH OUTLOOKTECH OUTLOOK
< Page 5 | Page 7 >